Leading Biopharmaceutical Experts Gather at the Market Access and Reimbursement Conference

Conference Brings Together Industry Leaders to Overcome Commercialization Challenges and Enhance Patient Access to Orphan Drugs
By: Michele Westergaard
 
Aug. 20, 2010 - PRLog -- marcus evans, a conference producing company, will host the Market Access and Reimbursement for Orphan Drugs and Rare Diseases Conference from November 15-17, 2010 in Philadelphia, PA. This conference will target senior level executives from Biopharmaceutical companies with responsibilities in Market Access, Pricing, Reimbursement and Rare Disease Research.

By attending this premiere conference, delegates will gain a better understanding of patient advocacy groups, payers and specialty pharmacies to access orphan drug populations. Attendees will have the opportunity to discuss critical issues, such as the Orphan Drug Act, while benchmarking their market access techniques in order to enhance and grow existing orphan drug portfolios.

Current speakers include leading experts such as Valery E. Gallagher, Director of U.S. State and Government Affairs at Baxter Healthcare, Ed Pezalla, National Medical Director and Chief Clinical Officer at Aetna Pharmacy Management and Susan Slaton, Director of Strategic Pricing and Reimbursement at Bayer Healthcare.

"We're pleased to have Valery Gallagher from Baxter International Inc. discussing the changing role of state government due to healthcare reform, and the opportunities Baxter has identified to help patients' access to orphan drugs," said James Grady, Conference Producer at marcus evans.

With a one-track focus, the Market Access and Reimbursement for Orphan Drugs and Rare Diseases Conference is a highly intensive, content driven event of case studies and panel discussions over two full days. This conference targets leaders of Market Access, Policy and Reimbursement functions in order to provide an intimate atmosphere for both delegates and speakers.

Attending this premiere conference will enable attendees to:
·   Discover the incentives of the Orphan Drug Act and other FDA programs for rare diseases
·   Enhance access to rare disease patients through commercialization and patient advocacy groups
·   Understand the insights, concerns and processes of specialty pharmacies and payers regarding orphan drugs
·   Utilize data and health technology assessment to reduce costs and increase perceived value of orphan drugs
·   Explore the differences between U.S. and Canadian approaches to orphan drug reimbursement

For more information on this conference or to get a complete list of speakers and sessions, visit http://www.marcusevansch.com/MarketAccess or email Michele Westergaard, Michelew@marcusevansch.com

About marcus evans
marcus evans conferences annually produce over 2,000 high quality events designed to provide key strategic business information, best practice and networking opportunities for senior industry decision-makers. Our global reach is utilized to attract over 30,000 speakers annually, ensuring niche focused subject matter presented directly by practitioners and a diversity of information to assist our clients in adopting best practice in all business disciplines.

Contact:
Michele Westergaard
Marketing/PR Coordinator
marcus evans
312-540-3000 ext. 6625
Michelew@marcusevansch.com

# # #

Marcus evans conferences annually produce over 2,000 high quality events designed to provide key strategic business information, best practice and networking opportunities for senior industry decision-makers.
End
Source:Michele Westergaard
Email:***@marcusevansch.com Email Verified
Zip:60611
Tags:Orphan Drugs, Rare Diseases, Pharmaceutical, Biotech, Event
Industry:Biotech, Medical, Event
Location:Chicago - Illinois - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
marcus evans Conferences News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share